Report Detail

Other COVID-19 Impact on Global Targeted DNA/RNA Sequencing Market Size, Status and Forecast 2020-2026

  • RnM4073682
  • |
  • 23 June, 2020
  • |
  • Global
  • |
  • 127 Pages
  • |
  • QYResearch
  • |
  • Other

This report focuses on the global Targeted DNA/RNA Sequencing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Targeted DNA/RNA Sequencing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
DNASTAR Inc.
QIAGEN
BGI
Perkin Elmer, Inc.
Pacific Biosciences of California, Inc.
Bio-Rad Laboratories, Inc.
Integrated DNA Technologies, Inc.
RainDance Technologies, Inc.
PierianDx
Genomatix GmbH
Macrogen, Inc.

Market segment by Type, the product can be split into
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Market segment by Application, split into
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Targeted DNA/RNA Sequencing status, future forecast, growth opportunity, key market and key players.
To present the Targeted DNA/RNA Sequencing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Targeted DNA/RNA Sequencing are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Targeted DNA/RNA Sequencing Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Targeted DNA/RNA Sequencing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 DNA-based Targeted Sequencing
    • 1.4.3 RNA-based Targeted Sequencing
  • 1.5 Market by Application
    • 1.5.1 Global Targeted DNA/RNA Sequencing Market Share by Application: 2020 VS 2026
    • 1.5.2 Human Biomedical Research
    • 1.5.3 Plant & Animal Sciences
    • 1.5.4 Drug Discovery
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Targeted DNA/RNA Sequencing Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Targeted DNA/RNA Sequencing Industry
      • 1.6.1.1 Targeted DNA/RNA Sequencing Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Targeted DNA/RNA Sequencing Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Targeted DNA/RNA Sequencing Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Targeted DNA/RNA Sequencing Market Perspective (2015-2026)
  • 2.2 Targeted DNA/RNA Sequencing Growth Trends by Regions
    • 2.2.1 Targeted DNA/RNA Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Targeted DNA/RNA Sequencing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Targeted DNA/RNA Sequencing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Targeted DNA/RNA Sequencing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Targeted DNA/RNA Sequencing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Targeted DNA/RNA Sequencing Players by Market Size
    • 3.1.1 Global Top Targeted DNA/RNA Sequencing Players by Revenue (2015-2020)
    • 3.1.2 Global Targeted DNA/RNA Sequencing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Targeted DNA/RNA Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Targeted DNA/RNA Sequencing Market Concentration Ratio
    • 3.2.1 Global Targeted DNA/RNA Sequencing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Targeted DNA/RNA Sequencing Revenue in 2019
  • 3.3 Targeted DNA/RNA Sequencing Key Players Head office and Area Served
  • 3.4 Key Players Targeted DNA/RNA Sequencing Product Solution and Service
  • 3.5 Date of Enter into Targeted DNA/RNA Sequencing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Targeted DNA/RNA Sequencing Historic Market Size by Type (2015-2020)
  • 4.2 Global Targeted DNA/RNA Sequencing Forecasted Market Size by Type (2021-2026)

5 Targeted DNA/RNA Sequencing Breakdown Data by Application (2015-2026)

  • 5.1 Global Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
  • 5.2 Global Targeted DNA/RNA Sequencing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Targeted DNA/RNA Sequencing Market Size (2015-2020)
  • 6.2 Targeted DNA/RNA Sequencing Key Players in North America (2019-2020)
  • 6.3 North America Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
  • 6.4 North America Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Targeted DNA/RNA Sequencing Market Size (2015-2020)
  • 7.2 Targeted DNA/RNA Sequencing Key Players in Europe (2019-2020)
  • 7.3 Europe Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
  • 7.4 Europe Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)

8 China

  • 8.1 China Targeted DNA/RNA Sequencing Market Size (2015-2020)
  • 8.2 Targeted DNA/RNA Sequencing Key Players in China (2019-2020)
  • 8.3 China Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
  • 8.4 China Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Targeted DNA/RNA Sequencing Market Size (2015-2020)
  • 9.2 Targeted DNA/RNA Sequencing Key Players in Japan (2019-2020)
  • 9.3 Japan Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
  • 9.4 Japan Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Targeted DNA/RNA Sequencing Market Size (2015-2020)
  • 10.2 Targeted DNA/RNA Sequencing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)

11 India

  • 11.1 India Targeted DNA/RNA Sequencing Market Size (2015-2020)
  • 11.2 Targeted DNA/RNA Sequencing Key Players in India (2019-2020)
  • 11.3 India Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
  • 11.4 India Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Targeted DNA/RNA Sequencing Market Size (2015-2020)
  • 12.2 Targeted DNA/RNA Sequencing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
  • 12.4 Central & South America Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Illumina, Inc.
    • 13.1.1 Illumina, Inc. Company Details
    • 13.1.2 Illumina, Inc. Business Overview and Its Total Revenue
    • 13.1.3 Illumina, Inc. Targeted DNA/RNA Sequencing Introduction
    • 13.1.4 Illumina, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020))
    • 13.1.5 Illumina, Inc. Recent Development
  • 13.2 F. Hoffmann-La Roche Ltd
    • 13.2.1 F. Hoffmann-La Roche Ltd Company Details
    • 13.2.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
    • 13.2.3 F. Hoffmann-La Roche Ltd Targeted DNA/RNA Sequencing Introduction
    • 13.2.4 F. Hoffmann-La Roche Ltd Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 13.2.5 F. Hoffmann-La Roche Ltd Recent Development
  • 13.3 Agilent Technologies
    • 13.3.1 Agilent Technologies Company Details
    • 13.3.2 Agilent Technologies Business Overview and Its Total Revenue
    • 13.3.3 Agilent Technologies Targeted DNA/RNA Sequencing Introduction
    • 13.3.4 Agilent Technologies Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 13.3.5 Agilent Technologies Recent Development
  • 13.4 GATC Biotech Ag
    • 13.4.1 GATC Biotech Ag Company Details
    • 13.4.2 GATC Biotech Ag Business Overview and Its Total Revenue
    • 13.4.3 GATC Biotech Ag Targeted DNA/RNA Sequencing Introduction
    • 13.4.4 GATC Biotech Ag Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 13.4.5 GATC Biotech Ag Recent Development
  • 13.5 Oxford Nanopore Technologies
    • 13.5.1 Oxford Nanopore Technologies Company Details
    • 13.5.2 Oxford Nanopore Technologies Business Overview and Its Total Revenue
    • 13.5.3 Oxford Nanopore Technologies Targeted DNA/RNA Sequencing Introduction
    • 13.5.4 Oxford Nanopore Technologies Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 13.5.5 Oxford Nanopore Technologies Recent Development
  • 13.6 Thermo Fisher Scientific, Inc.
    • 13.6.1 Thermo Fisher Scientific, Inc. Company Details
    • 13.6.2 Thermo Fisher Scientific, Inc. Business Overview and Its Total Revenue
    • 13.6.3 Thermo Fisher Scientific, Inc. Targeted DNA/RNA Sequencing Introduction
    • 13.6.4 Thermo Fisher Scientific, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 13.6.5 Thermo Fisher Scientific, Inc. Recent Development
  • 13.7 DNASTAR Inc.
    • 13.7.1 DNASTAR Inc. Company Details
    • 13.7.2 DNASTAR Inc. Business Overview and Its Total Revenue
    • 13.7.3 DNASTAR Inc. Targeted DNA/RNA Sequencing Introduction
    • 13.7.4 DNASTAR Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 13.7.5 DNASTAR Inc. Recent Development
  • 13.8 QIAGEN
    • 13.8.1 QIAGEN Company Details
    • 13.8.2 QIAGEN Business Overview and Its Total Revenue
    • 13.8.3 QIAGEN Targeted DNA/RNA Sequencing Introduction
    • 13.8.4 QIAGEN Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 13.8.5 QIAGEN Recent Development
  • 13.9 BGI
    • 13.9.1 BGI Company Details
    • 13.9.2 BGI Business Overview and Its Total Revenue
    • 13.9.3 BGI Targeted DNA/RNA Sequencing Introduction
    • 13.9.4 BGI Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 13.9.5 BGI Recent Development
  • 13.10 Perkin Elmer, Inc.
    • 13.10.1 Perkin Elmer, Inc. Company Details
    • 13.10.2 Perkin Elmer, Inc. Business Overview and Its Total Revenue
    • 13.10.3 Perkin Elmer, Inc. Targeted DNA/RNA Sequencing Introduction
    • 13.10.4 Perkin Elmer, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 13.10.5 Perkin Elmer, Inc. Recent Development
  • 13.11 Pacific Biosciences of California, Inc.
    • 10.11.1 Pacific Biosciences of California, Inc. Company Details
    • 10.11.2 Pacific Biosciences of California, Inc. Business Overview and Its Total Revenue
    • 10.11.3 Pacific Biosciences of California, Inc. Targeted DNA/RNA Sequencing Introduction
    • 10.11.4 Pacific Biosciences of California, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 10.11.5 Pacific Biosciences of California, Inc. Recent Development
  • 13.12 Bio-Rad Laboratories, Inc.
    • 10.12.1 Bio-Rad Laboratories, Inc. Company Details
    • 10.12.2 Bio-Rad Laboratories, Inc. Business Overview and Its Total Revenue
    • 10.12.3 Bio-Rad Laboratories, Inc. Targeted DNA/RNA Sequencing Introduction
    • 10.12.4 Bio-Rad Laboratories, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 10.12.5 Bio-Rad Laboratories, Inc. Recent Development
  • 13.13 Integrated DNA Technologies, Inc.
    • 10.13.1 Integrated DNA Technologies, Inc. Company Details
    • 10.13.2 Integrated DNA Technologies, Inc. Business Overview and Its Total Revenue
    • 10.13.3 Integrated DNA Technologies, Inc. Targeted DNA/RNA Sequencing Introduction
    • 10.13.4 Integrated DNA Technologies, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 10.13.5 Integrated DNA Technologies, Inc. Recent Development
  • 13.14 RainDance Technologies, Inc.
    • 10.14.1 RainDance Technologies, Inc. Company Details
    • 10.14.2 RainDance Technologies, Inc. Business Overview and Its Total Revenue
    • 10.14.3 RainDance Technologies, Inc. Targeted DNA/RNA Sequencing Introduction
    • 10.14.4 RainDance Technologies, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 10.14.5 RainDance Technologies, Inc. Recent Development
  • 13.15 PierianDx
    • 10.15.1 PierianDx Company Details
    • 10.15.2 PierianDx Business Overview and Its Total Revenue
    • 10.15.3 PierianDx Targeted DNA/RNA Sequencing Introduction
    • 10.15.4 PierianDx Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 10.15.5 PierianDx Recent Development
  • 13.16 Genomatix GmbH
    • 10.16.1 Genomatix GmbH Company Details
    • 10.16.2 Genomatix GmbH Business Overview and Its Total Revenue
    • 10.16.3 Genomatix GmbH Targeted DNA/RNA Sequencing Introduction
    • 10.16.4 Genomatix GmbH Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 10.16.5 Genomatix GmbH Recent Development
  • 13.17 Macrogen, Inc.
    • 10.17.1 Macrogen, Inc. Company Details
    • 10.17.2 Macrogen, Inc. Business Overview and Its Total Revenue
    • 10.17.3 Macrogen, Inc. Targeted DNA/RNA Sequencing Introduction
    • 10.17.4 Macrogen, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
    • 10.17.5 Macrogen, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Targeted DNA/RNA Sequencing. Industry analysis & Market Report on COVID-19 Impact on Global Targeted DNA/RNA Sequencing is a syndicated market report, published as COVID-19 Impact on Global Targeted DNA/RNA Sequencing Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Targeted DNA/RNA Sequencing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,123.90
    4,685.85
    6,247.80
    3,642.60
    5,463.90
    7,285.20
    614,211.00
    921,316.50
    1,228,422.00
    325,221.00
    487,831.50
    650,442.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report